文献速递肿瘤 PET/CT放射性药物与辐射防护

18F-FDG PET揭示高安动脉炎患者大血管炎症的独特特征

18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu's arteritis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-02-08

研究纳入30例高安动脉炎(TA)患者,于2010年10月至2014年4月同期行FDG PET/CT与MRI评估。30例中16例(53%)及177处血管病变中46处(26%)见FDG摄取增高;7例既往血管手术患者中6例(86%)、11个移植物中10个(91%)见移植物周围FDG摄取。PET/CT可揭示TA动脉受累的独特特征,移植物是潜在混杂因素,需前瞻性研究将PET发现与临床结局相关联。

要点

  • 30例TA患者中16例(53%)、177处血管病变中46处(26%)见FDG摄取增高。
  • 7例既往血管手术患者中6例(86%)、11个移植物中10个(91%)见移植物周围FDG摄取。
  • 39处显著FDG摄取病变中15处(38%)厚度<4 mm。

核心结论

  • PET/CT可揭示TA动脉受累的独特且基本特征,可能在随访中用于评估独立于全身炎症的局部炎症与血管重塑事件,即使动脉壁厚度<4 mm的病变亦如此。
  • 动脉移植物的存在是潜在混杂因素,需前瞻性研究将PET发现与相关临床结局相关联。

研究设计与样本

  • 研究纳入30例TA患者,于2010年10月至2014年4月期间同时接受PET/CT与MRI评估。
  • 对所有动脉病变行PET定性(阳性/阴性)与半定量(最大标准化摄取值,SUVmax)评估,并评估MRI视野内病变厚度。
  • 按患者分析评估PET数据与急性期反应物及NIH活动性TA标准的关系;按病变分析评估各病变PET特征与MRI形态学数据的关系;并评估动脉移植物存在的影响。

主要发现

  • 30例患者中16例(53%)、177处血管病变中46处(26%)见FDG摄取增高。
  • 7例既往血管手术患者中6例(86%)、11个移植物中10个(91%)见移植物周围FDG摄取。
  • 移植物相关摄取影响3例患者(10%)的PET结果及5例患者(17%)的SUVmax值。
  • 39处显著FDG摄取病变中15处(38%)厚度<4 mm;病变厚度仅在与FDG亲和病变中与病变SUVmax相关。
  • FDG动脉摄取与全身炎症或NIH标准无关。

关键数值与推荐

  • FDG摄取增高定义为PET定性阳性,半定量以SUVmax表示。
  • 活动性TA评估采用NIH标准。
  • 病变厚度以MRI视野内测量评估,关注<4 mm病变。

临床怎么用

  • 作者认为PET/CT可能在随访中用于评估独立于全身炎症的局部炎症与血管重塑事件,即使动脉壁厚度<4 mm的病变亦如此。
  • 作者指出动脉移植物的存在是潜在混杂因素。
  • 作者认为需前瞻性研究将PET发现与相关临床结局相关联。

局限性

  • 作者指出动脉移植物的存在是潜在混杂因素。
  • 作者指出需前瞻性研究将PET发现与相关临床结局相关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The object of this study was to assess whether 18F-fluorodeoxyglucose PET/CT (FDG PET/CT) provides novel information in patients with Takayasu's arteritis (TA) in addition to that provided by current activity assessment, to analyse the effects of possible confounders, such as arterial grafts, and to verify whether PET/CT could be informative in lesions <4 mm thick. METHODS: We studied 30 patients with TA, evaluated from October 2010 to April 2014 by both PET/CT and magnetic resonance imaging (MRI). All arterial lesions were evaluated by PET both qualitatively (positive/negative) and semiquantitatively (maximum standardized uptake value, SUVmax), and the thickness of lesions in the MRI field of view was evaluated. In a per-patient analysis, the relationships between the PET data and acute-phase reactants and NIH criteria for active TA were evaluated. In a per-lesion analysis, the relationships between the PET features of each lesion and MRI morphological data were evaluated. The effects of the presence of arterial grafts were also evaluated. RESULTS: Increased FDG uptake was seen in 16 of 30 patients (53%) and in 46 of 177 vascular lesions (26%). Significant periprosthetic FDG uptake was seen in 6 of 7 patients (86%) with previous vascular surgery and in 10 of 11 of grafts (91%). Graft-associated uptake influenced the PET results in three patients (10%) and the SUVmax values in five patients (17%). Of 39 lesions with significant FDG uptake, 15 (38%) were <4 mm thick. Lesion thickness was correlated with lesion SUVmax in FDG-avid lesions only. FDG arterial uptake was not associated with systemic inflammation or NIH criteria. CONCLUSIONS: PET/CT reveals unique and fundamental features of arterial involvement in TA. PET/CT may be useful in the assessment of local inflammatory and vascular remodelling events independent of systemic inflammation during follow-up, even in lesions in which the arterial wall is <4 mm. The presence of arterial grafts is a potential confounder. Prospective studies are required to correlate PET findings with relevant clinical outcomes.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Incerti E, Tombetti E, Fallanca F, et al. 18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu's arteritis. Eur J Nucl Med Mol Imaging. 2017. PMID: 28180963. doi:10.1007/s00259-017-3639-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。